Table 2.

Outcome measurement of both groups at baseline (T0^a) and posttest (T1^b) assessments.

Measure			Control group, mean (SD), range				Intervention group, mean (SD), range
		T0		T1		T0		T1
MUSEc
	All medications	27.0 (4.71), 16-32		27.6 (3.76) 20-32		26.3 (5.81), 16-32		30.1 (3.62), 20-32
	Hypertensived	36.2 (4.62), 17-32		27.8 (35.7), 22-32		26.3 (5.59), 16-32		30.1 (3.51), 20-32
	Antithrombotice	27.0 (4.70), 16-32		24.4 (3.73), 20-32		27.3 (5.43), 16-32		30.0 (3.57), 20-32
Systolic blood pressured (mmHg)		138.7 (7.84), 127-162		137.9 (10.78), 124-60		147.0 (16.8), 121-186		137.8 (12.74), 117-165
Diastolic blood pressured (mmHg)		79.6 (11.62), 54-107		80.0 (10.93), 60-105		85.7 (11.59), 58-109		85.0 (9.07), 68-100

^aT0: baseline (control group n=27, intervention group n=30).

^bT1: 3 months postrandomization (control group n=27, intervention group n=27).

^cMUSE: medication understanding and use self-efficacy.

^dPrescribed with antihypertensive medication and diagnosed with hypertension as a primary factor (control group n=24, intervention group n=26).

^ePrescribed antithrombotic medication as a prerequisite preventative treatment for stroke (control group n=27, intervention group n=27).